Introduction: Several studies have suggested that the presence of myeloid antigens is a poor prognostic factorin patients with acute lymphoid leukemia (ALL). Objective: We aimed to assess this possibility in Turkish patients.Materials and Methods: Seventy-three children with a diagnosis of ALL-L1 and 38 with ALL-L2 were included.Flow cytometry and fluorescein-isothiocynate conjugated antibodies were used to determined surface antigens onblasts. Results: Myeloid antigens were positive in 48.4% with ALL-L1 and 60.5% with ALL-L2, the differencenot being significant. Overall survival rates of myeloid antigen positive patients at 36, 60, and 72 months were76%, 58%, and 48%, respectively, comparable to the corresponding 70%, 56%, and 46% in myeloid antigennegative patients (p >0.05). Conclusion: We did not find any association between myeloid antigen positivity andclinical and laboratory features of ALL.
(2010). Myeloid Antigen Positivity in Turkish Children With Acute Lymphoblastic Leukemia Lacks Influence on Prognosis. Asian Pacific Journal of Cancer Prevention, 11(6), 1823-1826.
MLA
. "Myeloid Antigen Positivity in Turkish Children With Acute Lymphoblastic Leukemia Lacks Influence on Prognosis". Asian Pacific Journal of Cancer Prevention, 11, 6, 2010, 1823-1826.
HARVARD
(2010). 'Myeloid Antigen Positivity in Turkish Children With Acute Lymphoblastic Leukemia Lacks Influence on Prognosis', Asian Pacific Journal of Cancer Prevention, 11(6), pp. 1823-1826.
VANCOUVER
Myeloid Antigen Positivity in Turkish Children With Acute Lymphoblastic Leukemia Lacks Influence on Prognosis. Asian Pacific Journal of Cancer Prevention, 2010; 11(6): 1823-1826.